Incidence and Natural History of Pediatric Large Vessel Occlusion Stroke: A Population Study.
Journal
JAMA neurology
ISSN: 2168-6157
Titre abrégé: JAMA Neurol
Pays: United States
ID NLM: 101589536
Informations de publication
Date de publication:
01 05 2022
01 05 2022
Historique:
pubmed:
29
3
2022
medline:
12
5
2022
entrez:
28
3
2022
Statut:
ppublish
Résumé
The incidence and natural history of large vessel occlusion (LVO) stroke in children is largely unknown. These knowledge gaps limit the uptake of reperfusion therapies and reduce the efficiency of pediatric acute stroke pathways. To determine the incidence and natural history of pediatric LVO stroke. This retrospective population-based cohort study was conducted between January 2010 and December 2019, with a mean (SD) follow-up of 37.0 (28.8) months. Admissions from all pediatric hospitals in the state of New South Wales, Australia, with a final diagnosis of arterial ischemic stroke (AIS) in patients 1 month to younger than 17 years were included. A total of 85 of 251 identified cases were excluded based on selection criteria. Data were analyzed from July 2020 to June 2021. One-third of patients with LVO received mechanical thrombectomy with or without intravenous thrombolysis while the remainder were treated conservatively. The primary outcome was the pediatric modified Rankin Scale (ped-mRS) score 3 months after stroke. Ordinal logistic regression was used to compare non-LVO, LVO without thrombectomy, and LVO with thrombectomy groups. Of 161 included patients, 56 (34.8%) were female, and the mean (SD) age was 6.1 (5.4) years. A total of 166 AIS admissions were studied, and clinical follow-up was available for 164 of 166 admissions. LVO was present in 39 admissions (23.5%). The incidence of LVO stroke was 0.24 per 100 000 patients per year (95% CI, 0.13-0.35). Patients with LVO who did not receive thrombectomy (n = 26) had poor neurological outcomes, with 19 (73.1%) experiencing moderate to severe disability or death (ped-mRS score of 3 to 6) at 3 months (6 of 12 patients receiving thrombectomy [50.0%]; 25 of 38 patients with LVO [65.8%]). Patients with LVO without thrombectomy had significantly worse clinical outcomes than patients with non-LVO at 3 months (odds ratio, 3.64; 95% CI, 1.68-7.87; P = .001). Most patients with LVO presented within time windows suitable for thrombectomy (27 of 39 [69.2%] within 6 hours; 35 of 39 [89.7%] within 24 hours). In this population-based cohort study, the natural history of pediatric patients with LVO stroke treated conservatively was poor, with most experiencing lifelong disability or death. Nearly 90% of pediatric patients with LVO presented within time windows suitable for thrombectomy.
Identifiants
pubmed: 35344005
pii: 2790530
doi: 10.1001/jamaneurol.2022.0323
pmc: PMC8961400
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
488-497Références
Stroke. 2017 Dec;48(12):3397-3399
pubmed: 29070716
Neuropediatrics. 2005 Apr;36(2):90-7
pubmed: 15822021
Dev Med Child Neurol. 2020 Oct;62(10):1221-1223
pubmed: 31898325
N Engl J Med. 2015 Mar 12;372(11):1019-30
pubmed: 25671798
Ann Neurol. 2011 Aug;70(2):245-54
pubmed: 21823153
N Engl J Med. 2018 Jan 4;378(1):11-21
pubmed: 29129157
JAMA Neurol. 2020 Jan 1;77(1):25-34
pubmed: 31609380
Pediatrics. 2004 Jun;113(6):1642-52
pubmed: 15173485
Stroke. 2019 Dec;50(12):e344-e418
pubmed: 31662037
Stroke. 2019 Mar;50(3):e51-e96
pubmed: 30686119
N Engl J Med. 2015 Jun 11;372(24):2285-95
pubmed: 25882376
J Neurol Sci. 2007 Sep 15;260(1-2):256-60
pubmed: 17482211
Stroke. 2009 Dec;40(12):3834-40
pubmed: 19834014
J Stroke Cerebrovasc Dis. 2020 Feb;29(2):104504
pubmed: 31761735
Dev Med Child Neurol. 2013 May;55(5):434-9
pubmed: 23398238
Neurosurgery. 2019 Jul 1;85(suppl_1):S4-S8
pubmed: 31197329
N Engl J Med. 2015 Jan 1;372(1):11-20
pubmed: 25517348
N Engl J Med. 2015 Mar 12;372(11):1009-18
pubmed: 25671797
J Neurosurg Pediatr. 2019 Aug 9;:1-14
pubmed: 31398697
Int J Stroke. 2019 Jan;14(1):94-106
pubmed: 30284961
Int J Stroke. 2017 Oct;12(8):896-905
pubmed: 28946832
Pediatr Neurol. 2018 Sep;86:5-18
pubmed: 30122281
Pediatr Neurol. 2017 Apr;69:58-70
pubmed: 28254555
J Pediatr. 2020 Jan;216:136-141.e6
pubmed: 31704052
N Engl J Med. 2015 Jun 11;372(24):2296-306
pubmed: 25882510
Lancet. 2016 Apr 23;387(10029):1723-31
pubmed: 26898852
Nat Rev Neurol. 2010 Feb;6(2):64-6
pubmed: 20139995
Stroke. 2015 Mar;46(3):880-5
pubmed: 25613306
Stroke. 2009 Jan;40(1):52-7
pubmed: 18787197